Top medical group presses RFK Jr. to keep health screening panel
The American Medical Association (AMA) wrote to Kennedy on Sunday to express its 'deep concern' over reporting that Kennedy is planning to dismiss all members of the United States Preventive Services Task Force (USPSTF).
'USPSTF members have been selected through an open, public nomination process and are nationally recognized experts in primary care, prevention and evidence-based medicine. They serve on a volunteer basis, dedicating their time to help reduce disease and improve the health of all Americans—a mission well-aligned with the Make America Healthy Again initiative,' the AMA wrote in a letter to Kennedy.
The Wall Street Journal reported late last week that Kennedy was planning to dismiss the entire 16-member panel for being too 'woke' in his eyes, citing people familiar with the decision. The report comes after Kennedy in June dismissed the entire Advisory Committee on Immunization Practices for the Centers for Disease Control and Prevention, replacing the members with some known spreaders of vaccine information.
When reached for comment by The Hill, a spokesperson the Department of Health and Human Services (HHS) said, 'No final decision has been made on how the USPSTF can better support HHS' mandate to Make America Healthy Again.'
Just last month, the USPSTF's powers to make recommendations survived legal scrutiny when the Supreme Court upheld their constitutionality. Plaintiffs in the case argued the panel was unconstitutional. The case began when a Texas business did not wish to cover HIV pre-exposure prophylaxis, which is recommended by the USPSTF.
'Given the essential role USPSTF members play in weighing the benefits and harms of preventive services such as screenings, behavioral counseling, and preventive medications, and making evidence-based recommendations for implementation in primary care settings, we urge you to keep the previously appointed USPSTF members and continue the task force's regular meeting schedule to ensure recommendations are put forth, updated, and disseminated without delay,' the AMA told Kennedy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
24 minutes ago
- CNBC
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
For once, the Trump administration may be giving some drugmakers a reason to celebrate. The Trump administration is planning to experiment with covering costly weight loss drugs under Medicare and Medicaid, the Washington Post reported on Friday. That plan could expand access to millions of Americans with obesity who can't currently afford Novo Nordisk's Wegovy and Eli Lilly's Zepbound, blockbuster GLP-1 drugs that cost around $1,000 per month before insurance. In a statement to CNBC about the plan, the Department of Health and Human Services said all drug coverages undergo a "cost-benefit review." The Centers for Medicare and Medicaid Services "does not comment on potential models or coverage," the department added. The reported plan – if it ultimately takes effect – would be a huge win for Eli Lilly, Novo Nordisk and many Americans. Spotty insurance coverage of obesity drugs remains the biggest barrier to access for patients – and it's choking broader uptake and revenue growth for the two pharmaceutical giants. Many health plans, including Medicare, cover GLP-1s for treatment of diabetes, but not obesity. Medicaid coverage of obesity drugs is limited and varies by state, according to health policy research organization KFF. But it's important to remember that this plan isn't exactly new. In November, the Biden administration proposed having Medicare and Medicaid cover obesity treatments, which would have extended access to roughly 3.4 million Medicare beneficiaries and about 4 million Medicaid recipients. The proposal was controversial at the time, as it would cost taxpayers as much as $35 billion over the next decade, a congressional analysis found. The Trump administration dropped that proposal in April, but said it could reconsider coverage of those drugs in the future. Let's get into what the newest reported iteration of the plan looks like. Under the Trump administration's reported pilot plan, state Medicaid programs and Medicare Part D plans would be able to voluntarily choose to cover Ozempic, Wegovy, Mounjaro and Zepbound for patients for "weight management" purposes. That's according to several Centers for Medicare and Medicaid Services documents obtained by the Post. The plan is expected to start in April 2026 for Medicaid and January 2027 for Medicare plans, the Post reported. It's unclear how exactly the plan will play out, Jared Holz, Mizuho health care equity strategist, said in a note to clients on Friday. Holz said he expects the government to put some coverage parameters in place related to factors like age, body weight, body mass index and other comorbidities, or coexisting chronic health conditions. He also said the pricing of the drugs will be a "major consideration." Holz said he expects the government to pay less than the current list prices of drugs. But having that coverage would expand access and could help drive higher sales volumes, he noted. Another factor to consider is how much the government is willing to crack down on so-called compounding pharmacies, which are allowed in rare cases to sell cheaper, unapproved versions of GLP-1s. The pharmaceutical industry fiercely opposes those knock-off GLP-1s, as their safety and efficacy aren't vetted by regulators and they are, in some cases, illegally sold at scale. Holz said the industry's complaints to the government about compounded GLP-1s have so far "not been met with a widespread shut-down." But overall, Holz said the Trump administration's reported willingness to consider covering obesity drugs is "a slight positive as far as industry sentiment." It's definitely a breath of fresh air for Eli Lilly, Novo Nordisk and other drugmakers – including Amgen, Roche, AstraZeneca and Pfizer – that are hoping to bring their own obesity drugs to market. The last six months have been anything but smooth for the broader industry: The Trump administration has ratcheted up calls for drugmakers to lower U.S. drug prices, overhauled federal health agencies and could impose sweeping tariffs on pharmaceuticals imported into the country any day now. We'll keep watching to see whether this plan gets implemented, so stay tuned for our coverage! Feel free to send any tips, suggestions, story ideas and data to Annika at After reporting its second straight earnings miss and guidance cut, UnitedHealth Group completed its executive sweep by replacing CFO John Rex. Executives on the earnings call admitted to mis-execution in Medicare Advantage and pledged to get back to profitability and win back investor trust. Nearly two years ago it was CVS Health under pressure, after profits in the company's Aetna health insurance division were torpedoed by low Medicare Advantage Star quality ratings. This week, CVS beat and raised its outlook on the strength of its MA program. CEO David Joyner, now one year into the job, told me he feels good about the turnaround at Aetna and its Medicare business. On top of that, the company saw market share gains in its stores, thanks in part to winning over Rite Aid customers. Humana, similarly, has seen progress on its turnaround, but CFO Celeste Mellet told me that all insurers are grappling with pricing plans for next year amid high medical costs. One big cost driver right now, Mellet told CNBC, is oncology drugs, as some expensive therapies are now being used in combination. The next moment of truth for the Medicare Advantage players will come over the next six weeks – when they'll learn the fate of their Star ratings for 2026 plans. Long-time health-care executive Dr. Marc Harrison has stepped down as CEO of General Catalyst's Health Assurance Transformation Company, or HATCo, and has moved into a strategic advisor role, CNBC has confirmed. The venture capital firm brought in Harrison and announced the formation of HATCo in 2023. In a release at the time, General Catalyst said the company would work closely with health system partners, and that it would eventually acquire and operate its own health system. Months later, HATCo announced its plans to buy Summa Health, a nonprofit integrated health system in northeast Ohio. Under its new structure, Summa would become a for-profit organization, and General Catalyst said it would introduce new tech-enabled solutions that aim to make care more accessible and affordable. Buying a health system is an unprecedented move in the venture industry, and the deal wasn't well received by some members of the Ohio community. Hundreds signed a petition urging Summa to remain a nonprofit and to halt negotiations with HATCo. Ohio Attorney General Dave Yost conditionally approved the deal in June, though he outlined a number of "enforceable commitments" as part of the agreement. HATCo will have to notify the Attorney General of transactions that could trigger antitrust concerns for 10 years after the deal closes, for instance. Harrison went to medical school in the late 1980s and has spent most of his career within health systems, most recently as CEO of Intermountain Healthcare. General Catalyst told CNBC that Harrison will continue to provide the firm's CEO, Hemant Taneja, with clinical insights and will remain connected to its ecosystem in his new role. "It became increasingly clear to both Marc and to us that Marc's role would best be accomplished as a strategic advisor to Hemant Taneja as we bring that ambition and vision to life," a General Catalyst spokesperson said. Daryl Tol, the head of General Catalyst's Health Assurance Ecosystem, was promoted to president of HATCo, the spokesperson said. He will spearhead the firm's day-to-day- work with Summa Health leadership. General Catalyst has also appointed Kate Walsh, the former Massachusetts Secretary of Health and Human Services, to HATCo's board. In addition, she will serve as the chair of the board at Summa Health once the transaction closes. "We are grateful for Marc's leadership and collaboration as co-founder and CEO to help get us to this point in the evolution of HATCo, and we look forward to leveraging his invaluable perspective as we continue to progress," the spokesperson said.
The Hill
25 minutes ago
- The Hill
DHS uses ‘South Park' image for recruitment ahead of ICE-themed episode
The Department of Homeland Security (DHS) on Tuesday used imagery from 'South Park,' which had dedicated its season premiere to mocking President Trump, to encourage recruitment for Immigration and Customs Enforcement (ICE) ahead of the show's next episode, which deals with Trump immigration enforcement. On the social platform X, the DHS account posted an image of the show's animation with several people loaded into a car labeled ICE. Several similar vehicles followed in the background, with one appearing to sound its siren. All the characters in the ICE vehicles were depicted wearing masks covering the lower halves of their faces. ' DHS wrote in the photo's caption, linking to the recruitment site. The DHS post came shortly after South Park released a teaser for its next episode, featuring an animation of a woman closely resembling DHS Secretary Kristi Noem. That character is depicted pointing a gun in the air, wearing a 'POLICE ICE' vest and posing in front of photographers. Noem has previously faced criticism for calling in the media during ICE-related operations. ''Got A Nut': When Mr. Mackay loses his job, he desperately tries to find a new way to make a living,' the South Park account posted on X, teasing the next episode, which is set to air Wednesday evening on Comedy Central and the next day on Paramount+. In a subsequent statement to Newsweek, DHS thanked the show for helping its recruitment efforts. 'We want to thank South Park for drawing attention to ICE law enforcement recruitment,' a DHS spokesperson said in the statement. 'We are calling on patriotic Americans to help us remove murderers, gang members, pedophiles, and other violent criminals from our country. Benefits available to new ICE recruits include an up to $50,000 signing bonus, student loan forgiveness, and retirement benefits. Apply today at the spokesperson continued. South Park's 27th season, which premiered two weeks ago, has targeted the White House and the president directly. In the debut episode this season, the show depicted Trump naked in bed with the devil and made fun of what the show depicted as small genitals. The season premiere poked fun at Trump for targeting his enemies and mocked media conglomerate Paramount over its recent settlement with the president, which came ahead of its merger with Skydance that required the approval of Trump's Federal Communications Commission. The season premiered just days after the creators of 'South Park,' Trey Parker and Matt Stone, reached a massive streaming deal with Paramount, valued at more than $1 billion.
New York Post
25 minutes ago
- New York Post
Democrats howling at Texas redistrict push should take a look in the mirror
Let's take a tour of the 13th congressional district in Illinois. It starts in East St. Louis and then moves steadily north. By the time it gets to Springfield, home of Abraham Lincoln, about 90 miles away, it takes a sharp turn to the east, reaching Decatur and finally Champaign, itself about 80 miles away from Springfield. Advertisement It's a jagged, narrow strip of territory with no obvious rhyme or reason as it traverses six counties. It's less a congressional district than a road trip, and bears a resemblance to the original gerrymander, a long, salamander-like state Senate district in Massachusetts in 1812. The only point of the new 13th district lines, fashioned in the redistricting after the 2020 census, was to gather together far-flung Democrats to create another Democratic congressional district. Advertisement Mission accomplished: The 13th went from being a competitive district long held by a Republican to flipping to the Democrats in 2022. Overall, Illinois lost one district after the 2020 census and managed to write lines that changed the congressional ratio from a 13-5 Democratic advantage to a 14-3 Democratic advantage. The political analysis website 538 called the new map 'the worst gerrymander in the country drawn by Democrats.' Advertisement This makes it especially inapt that a contingent of Texas Democrats fleeing the Lone Star state to try to stop what they consider unfair new congressional boundaries found a safe harbor in Illinois. Next time their travel agent should do a hypocrisy check before booking a destination. Illinois Gov. JB Pritzker welcomed the self-exiling Democrats and hailed their courage. He told them that he and other top Democrats in the state were pleased 'to stand in solidarity with you and send a clear message to all Americans.' Advertisement His conscience showed no sign of being pricked by the fact that he signed into law the redistricting that saw Republicans in 2022 win nearly 44% of the popular vote in Illinois congressional races — and only 18% of the congressional seats. A special session of the Texas Legislature is considering new lines that could net Republicans another five House seats. Gov. Greg Abbott has cited a Department of Justice letter saying that some of the current districts need to be redrawn because they represent unconstitutional racial gerrymandering (the Biden Justice Department had been fighting Texas because, in its view, the current lines didn't reflect enough racial gerrymandering). The Supreme Court is taking up a Louisiana case that should clarify the extent to which states can consider race in drawing so-called majority-minority districts. In the meantime, the partisan effect of the new Texas lines before the 2026 mid-terms is unmistakable: If Republicans were likely to lose five seats from this redistricting, there's no doubt that the state's Republican governor and Republican legislature wouldn't be undertaking it. Drawing district lines is an inherently political enterprise, and parties tend to give themselves the best of it. When Democrats controlled the Texas Legislature, they maintained congressional lines in their favor. Advertisement It wasn't until 2002, when Republicans won the state house for the first time since Reconstruction, that the GOP could redraw the congressional map — and Republicans subsequently won a majority of Texas congressional seats in 2004, also for the first time since Reconstruction. Since Democrats gerrymander too, they have limited options for retaliating against Texas. Pritzker says he may re-draw his state's lines, but this would require gerrymandering on top of his current gerrymander. Advertisement Gavin Newsom is making similar noises, but the California map is already tilted toward Democrats: Republicans won nearly 40% of the congressional vote in the Golden State in 2024, but only about 17% of the seats. If the Texas plan goes through and all else remains equal, the Lone Star state will have about the same partisan skew as California. Less gerrymandering would be better than more, but Democrats like Pritzker, who blessed his state's meandering 13th district, have no standing to make the case. Twitter: @RichLowry
